China Molecular Diagnostics Market, Volume, by Application [Oncology Testing (Breast Cancer, Colorectal Cancer, Prostate Cancer), Infectious Disease Testing (Virology, HPV), and Genetic Disease Testing (Blood Screening, HLA)]中国の分子診断学市場 この調査レポートは中国の分子診断学市場を分析・予測したRenub Researchの市場調査報告書です。 Overview Molecular diagnostics plays an important role in the identification of diseases and has ga... もっと見る
Summaryこの調査レポートは中国の分子診断学市場を分析・予測したRenub Researchの市場調査報告書です。 Overview Molecular diagnostics plays an important role in the identification of diseases and has gained more public & healthcare specialist attention than ever before. The molecular diagnostics is a technique used for the molecular biological detection of any change in the structure or expression of a patient's genetic material. According to Renub Research, China Molecular Diagnostics Market is expected to be US$ 6.3 Billion by 2026. COVID-19 effect on Molecular Diagnostics Industry China molecular diagnostics market is segmented into three main categories: Oncology Test, Infectious Disease Test and Genetic Disease Test. Further, Oncology Test has been segmented into three types: Prostate Cancer, Colorectal Cancer and Breast Cancer. Infectious Disease Test has been further categorized into two main types, which is virology and HPV. Genetic Test has been categorized into HLA and Blood Screening. Blood screening test is a dominating segment in the China molecular genetic testing market. According to Renub Research analysis nearly 441 million molecular diagnostic tests will be performed in China by the end of 2026 of which Virology accounts for one of the most performed tests segments. DICON Clinical Laboratories, Zhejiang Di’an Diagnostics Technology Co., Ltd, Kindstar Global, BGI-Shenzhen, A, Guangzhou Kingmed Diagnostics Center Co. Ltd and OriGene Technologies holds majority of market share in China. However, restriction on export is expected to have minimal impact on the manufacturers as the demand is very high in China which is creating a robust revenue pool for manufacturers dealing in the molecular diagnostics sector. Renub Research report titled “China Molecular Diagnostics Market, Volume, by Application [Oncology Testing (Breast Cancer, Colorectal Cancer, Prostate Cancer), Infectious Disease Testing (Virology, HPV), and Genetic Disease Testing (Blood Screening, HLA)]” provides a complete analysis of China Molecular Diagnostics Market. By Application Segment Covered in this report are as follows: Genetic Testing Market and Volume Profiles of Private Clinical Labs and Diagnostic Services Companies in China Table of ContentsTable of Contents 1. Introduction 4. Market Dynamics 5. China Molecular Diagnostic Market & Test Volume 6. Market Share - China Molecular Diagnostic Share Analysis 7. Volume Share - China Molecular Diagnostics 8. Disease - China Molecular Diagnostic Test Volume 9. Disease - China Molecular Diagnostic Market 10. China Healthcare Insurance Schemes 11. Profiles of Private Clinical Labs and Diagnostic Services Companies List of Tables List of Tables: List of Figures List of Figures:Figure 3-1: China - Healthcare Spending (Billion US$), 2011 & 2020 Figure 4-1: China - Molecular Diagnostic Market (Million US$), 2015 - 2019 Figure 4-2: China - Forecast for Molecular Diagnostic Market (Million US$), 2020 - 2026 Figure 4-3: China - Molecular Diagnostic Test Volume (Million), 2015 - 2019 Figure 4-4: China - Forecast for Molecular Diagnostic Test Volume (Million), 2020 - 2026 Figure 5-1: China - Molecular Diagnostic Market Share (Percent), 2015 - 2019 Figure 5-2: China - Forecast for Molecular Diagnostic Market Share (Percent), 2020 - 2026 Figure 5-3: China - Molecular Oncology Test Market Share (Percent), 2015 - 2019 Figure 5-4: China - Forecast for Molecular Oncology Test Market Share (Percent), 2020 - 2026 Figure 6-1: China - Molecular Diagnostic Test Volume Share (Percent), 2015 - 2019 Figure 6-2: China - Forecast for Molecular Diagnostic Test Volume Share (Percent), 2020- 2026 Figure 6-3: China - Molecular Oncology Test Volume Share (Percent), 2015 - 2019 Figure 6-4: China - Forecast for Molecular Oncology Test Volume Share (Percent), 2020 - 2026 Figure 7-1: Rural China - Cancer Screening Sites by Cancer Type (Number), 2013 Figure 7-2: China - Oncology Test Volume (Million), 2015 - 2019 Figure 7-3: China - Forecast for Oncology Test Volume (Million), 2020 - 2026 Figure 7-4: China - Breast Cancer Molecular Test Volume (Million), 2015 - 2019 Figure 7-5: China - Forecast for Breast Cancer Molecular Test Volume (Million), 2020 - 2026 Figure 7-6: China - Colorectal Cancer Test Volume (Million), 2015 - 2019 Figure 7-7: China - Forecast for Colorectal Cancer Test Volume (Million), 2020 - 2026 Figure 7-8: China - Prostate Cancer Test Volume (Million), 2015 - 2019 Figure 7-9: China - Forecast for Prostate Cancer Test Volume (Million), 2020 - 2026 Figure 7-10: China - Infectious Disease Test Volume (Million), 2015 - 2019 Figure 7-11: China - Forecast for Infectious Disease Test Volume (Million), 2020 - 2026 Figure 7-12: China - Virology Test Volume (Million), 2015 - 2019 Figure 7-13: China - Forecast for Virology Test Volume (Million), 2020 - 2026 Figure 7-14: China - HPV Test Volume (Thousand), 2015 - 2019 Figure 7-15: China - Forecast for HPV Test Volume (Thousand), 2020 - 2026 Figure 7-16: China - Genetic Test Volume (Million), 2015 - 2019 Figure 7-17: China - Forecast for Genetic Test Volume (Million), 2020 - 2026 Figure 7-18: China - Blood Screening Test Volume (Million), 2015 - 2019 Figure 7-19: China - Forecast for Blood Screening Test Volume (Million), 2020 - 2026 Figure 7-20: China - HLA Test Volume (Thousand), 2015 - 2019 Figure 7-21: China - Forecast for HLA Test Volume (Thousand), 2020 - 2026 Figure 8-1: China - Oncology Testing Market (Million US$), 2015 - 2019 Figure 8-2: China - Forecast for Oncology Testing Market (Million US$), 2020 - 2026 Figure 8-3: China - Breast Cancer Testing Market (Million US$), 2015 - 2019 Figure 8-4: China - Forecast for Breast Cancer Testing Market (Million US$), 2020 - 2026 Figure 8-5: China - Colorectal Cancer Testing Market (Million US$), 2015 - 2019 Figure 8-6: China - Forecast for Colorectal Cancer Testing Market (Million US$), 2020 - 2026 Figure 8-7: China - Prostate Cancer Testing Market (Million US$), 2015 - 2019 Figure 8-8: China - Forecast for Prostate Cancer Testing Market (Million US$), 2020 - 2026 Figure 8-9: China - Infectious Disease Testing Market (Million US$), 2015 - 2019 Figure 8-10: China - Forecast for Infectious Disease Testing Market (Million US$), 2020 - 2026 Figure 8-11: China - Virology Testing Market (Million US$), 2015 - 2019 Figure 8-12: China - Forecast for Virology Testing Market (Million US$), 2020 - 2026 Figure 8-13: China - HPV Testing Market (Million US$), 2015 - 2019 Figure 8-14: China - Forecast for HPV Testing Market (Million US$), 2020 - 2026 Figure 8-15: China - Genetic Testing Market (Million US$), 2015 - 2019 Figure 8-16: China - Forecast for Genetic Testing Market (Million US$), 2020- 2026 Figure 8-17: China - Blood Screening Market (Million US$), 2015 - 2019 Figure 8-18: China - Forecast for Blood Screening Market (Million US$), 2020 - 2026 Figure 8-19: China - HLA Testing Market (Million US$), 2015 - 2019 Figure 8-20: China - Forecast for HLA Testing Market (Million US$), 2020 - 2026 Figure 10-10-1: Kindstar - Collaboration with Hospitals in China (Number), 2006 - 2012
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(薬学的薬物)の最新刊レポートRenub Research社のその他分野での最新刊レポート
本レポートと同じKEY WORD(blood)の最新刊レポートよくあるご質問Renub Research社はどのような調査会社ですか?Renubリサーチ (Renub Research)は、インドに本社を置く調査会社です。通信や医薬市場について、市場動向や技術はもちろん、企業レポートや医療観光(メディカルツーリズム)など、幅広い関連... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |